Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma-Reference-Cited by-同舟云学术

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Published:2022-12-08 Issue:23 Volume:387 Page:2113-2125
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Rohaan Maartje W.¹,Borch Troels H.¹,van den Berg Joost H.¹,Met Özcan¹,Kessels Rob¹,Geukes Foppen Marnix H.¹,Stoltenborg Granhøj Joachim¹,Nuijen Bastiaan¹,Nijenhuis Cynthia¹,Jedema Inge¹,van Zon Maaike¹,Scheij Saskia¹,Beijnen Jos H.¹,Hansen Marten¹,Voermans Carlijn¹,Noringriis Inge M.¹,Monberg Tine J.¹,Holmstroem Rikke B.¹,Wever Lidwina D.V.¹,van Dijk Marloes¹,Grijpink-Ongering Lindsay G.¹,Valkenet Ludy H.M.¹,Torres Acosta Alejandro¹,Karger Matthias¹,Borgers Jessica S.W.¹^ORCID,ten Ham Renske M.T.¹,Retèl Valesca P.¹,van Harten Wim H.¹,Lalezari Ferry¹,van Tinteren Harm¹,van der Veldt Astrid A.M.¹,Hospers Geke A.P.¹,Stevense-den Boer Marion A.M.¹,Suijkerbuijk Karijn P.M.¹,Aarts Maureen J.B.¹,Piersma Djura¹,van den Eertwegh Alfons J.M.¹,de Groot Jan-Willem B.¹,Vreugdenhil Gerard¹,Kapiteijn Ellen¹,Boers-Sonderen Marye J.¹,Fiets W. Edward¹,van den Berkmortel Franchette W.P.J.¹,Ellebaek Eva¹,Hölmich Lisbet R.¹,van Akkooi Alexander C.J.¹,van Houdt Winan J.¹,Wouters Michel W.J.M.¹,van Thienen Johannes V.¹,Blank Christian U.¹,Meerveld-Eggink Aafke¹,Klobuch Sebastian¹,Wilgenhof Sofie¹,Schumacher Ton N.¹,Donia Marco¹^ORCID,Svane Inge Marie¹,Haanen John B.A.G.¹

Affiliation:

1. From the Division of Medical Oncology (M.W.R., M.H.G.F., M.K., J.S.W.B., J.V.T., C.U.B., A.M.-E., S.K., S.W., J.B.A.G.H.), the BioTherapeutics Unit, Hospital Pharmacy (J.H. van den Berg, C.N., M.Z., S.S.), the Divisions of Pharmacy and Pharmacology (B.N., J.H. Beijnen), Molecular Oncology and Immunology (I.J., T.N.S., J.B.A.G.H.), Biometrics (R.K., L.D.V.W., M. van Dijk, L.G.G.-O., L.H.M.V., A.T.A., H.T.), Psychosocial Research and Epidemiology (R.M.T.H., V.P.R., W.H.H.), Radiology (F.L.), and Surgical...

Funder

KWF Kankerbestrijding

Netherlands Organization for Health Research and Development

Dutch Ministry of Health

Stichting Avento

Copenhagen University Hospital

Danish Cancer Society

Capital Region of Denmark Research Foundation

AVL Foundation

Publisher

Massachusetts Medical Society

Subject